# Gabapentin

## Neurontin 100mg

| TAH Drug Code      | [ONEU1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONEU1){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Adjunctive therapy for the treatment of partial seizures with and without secondary generalization in adults and pediatric patients 3 years and older and postherpetic neuralgia in patients 18 years and older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | Epilepsy: Adults and pediatric patients 12 years and older: 900-1800 mg/day divided equally into three doses. The Initial dose is 300 mg TID. Dosages can then be titrated up as needed to a maximum of 1800 mg/day in three divided doses. Doses up to 2400 mg/day have shown good tolerability in some patients. Doses should not exceed 12 hour intervals to prevent breakthrough seizures. Pediatric patients aged 3-12 years: Initial dose range 0-15 mg/kg/day given TID. Aged >=5 years: 25-35 mg/kg/day divided into three doses. Aged 3 to <5 years: 40 mg/kg/day divided into three doses. Maximum dose: 50 mg/kg/day. Doses should not exceed 12 hour intervals. Therapeutic drug monitoring of gabapentin plasma concentrations is not required. Gabapentin may be used in combination with other antiepileptic drugs without concern for alteration of gabapentin concentrations or concentrations of concomitant antiepileptic drugs. Neuropathic Pain in Adults: Initial dose 900 mg/day divided TID. Maximum dose 1800 mg/day. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Hypersensitivity to gabapentin or any component of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | Common: Peripheral edema (1.7-8.3%), Nausea (Greater than 1%), Vomiting (3.3%), Viral disease (10.9%), Ataxia (Adult, 3%; adult and adolescent, 13%), Nystagmus (Adult and adolescent, 8%), Fatigue (3-11%), Fever (Pediatric, 10%) Serious: Stevens-Johnson syndrome, Hypoglycemia, Anaphylaxis, Drug reaction with eosinophilia and systemic symptoms, Dizziness (Adults, 28%; adults and adolescents, 17%; pediatrics, 3%), Somnolence (Adults, 21%; adults and adolescents, 19%; pediatrics, 8%), Disorder of form of thought (Pediatric, 1.7%), Disturbance in thinking (2-3%), Hostile behavior (Pediatric, 5.2%), Hyperactive behavior (Pediatric, 4.7%), Mood swings (Pediatric, 6%), Suicidal thoughts, Respiratory depression, Angioedema                                                                                                                                                                                                                                                                                            |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/gabapentin-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

